

ARM Holdings: Nomura keeps neutral rating and 580p target; Nomura maintains hold rating and 575p target; Peel Hunt keeps hold and 580p target. Nation...


Veterinary pharmaceutical firm Dechra Pharmaceuticals has reported that group revenue for the six months ended 31 December was around 9.1% ahead of th...


Unilever: Bank of America Merrill Lynch downgrades to underweight from neutral. Aggreko: Credit Suisse downgrades to neutral from outperform. Capit...


The first three months of the financial year started well at animal health-care group Dechra. Revenue in the first quarter is 7.7% ahead of the same p...


The reluctance of pet-owners' to neglect their animals despite tough economic conditions helped Dechra Pharmaceuticals post a rise in profits in the y...


Ladbrokes' shares have suffered this year, by comparison with its main quoted peer, William Hill. One reason for this is William Hill's symbiotic rela...


Veterinary pharmaceutical group Dechra Pharmaceuticals expects sales for the year ended 30 June to be 5.1% ahead of last year, slightly under consensu...


It was more of the same for Dechra Pharmaceuticals in the third quarter of its financial year as the first half's trends continued. The veterinary pr...